Skip to main content
Premium Trial:

Request an Annual Quote

Personalized Medicine Guilford Initiative Gears up with $2.2M DOD Funding


The promise of personalized medicine has been long heralded, to be sure, but a program in central North Carolina is taking steps to transform the talk into clinical reality.

The Guilford Genomic Medicine Initiative is a collaborative effort bringing together about 30 people at three partner institutions: the Moses Cone Health System, the Duke University Center for Human Genetics, and the University of North Carolina at Greensboro. “We’re really working as a partnership,” says Vincent Henrich, director of the Institute for Health, Science and Society at UNC Greensboro. “There’s a lot of communication going on, and I think that’s been essential for us in terms of making this really move forward.”

Also moving the project forward is funding from the latest defense appropriations bill to the tune of $2.2 million dollars. Three years ago, the project kicked off with initial defense funding in the amount of $3.4 million.

It was a confluence of ideas that sparked the GGMI about six years ago, recalls Margaret Pericak-Vance, director of the Duke University Center for Human Genetics. It was then that Pericak-Vance and her husband, Jeffery Vance — a neurologist, medical geneticist, and associate director of the center — started talking about setting up a model to incorporate the latest findings in genomics with clinical care. Around that time, Patricia Sullivan, chancellor at UNC Greensboro and Pericak-Vance’s old biology prof, was setting up the state’s first and only genetic counseling graduate program. Pericak-Vance saw the synergy at once and signed Sullivan on to the project. As she tells it, “[UNC Greensboro] has the genetic counseling school, the excellent education, and we have the informatics and genomics background. We’re both interested in personalized or genomic medicine, so the idea was to take all of our expertise and put them together.”

Henrich leads the project’s educational core, which is committed to developing programs designed to teach healthcare workers and members of the community about what it means to bring genomics to the bedside. He says the project’s goal is to “educate the physicians, the community, the patients about genomic medicine to the point where they feel comfortable and informed enough to have a dialogue.”

Another component, Henrich says, is “working with the community health system, which we’re doing with the Moses Cone Healthcare Center.” That center provides primary clinical sites and administers the program’s DOD funding and subcontracting to partner institutions.

Although the program is initially looking at genetic risk factors associated with thrombosis as well as breast and ovarian cancers, Pericak-Vance stresses that “the diseases themselves are instruments for us to see how to develop a model” for clinical practice. One of the applications for the GGMI model will be the US military healthcare system, says Henrich.

— Jen Crebs

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.